Author | Mark L. Fuerst

Articles

Universal screening for HCV infection is cost-effective

Article

Study suggests all adults age 18 and older should be screened for HCV.

Half of hepatitis C patients can receive shorter direct-acting antiviral treatments

Article

Shorter treatment could significantly reduce costs of therapy.

Too few young opioid drug users tested for hepatitis C infection

Article

Effective direct-acting antivirals are available for teens.

Hepatitis C drug treatments effective for inject drug users

Article

Strong evidence supports removal of restrictions to direct-acting antiviral therapy based on recent drug use.